ORKA Q1 2020 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$25,000

Operating Income

-$1M

Net Income

-$1M

EPS (Diluted)

$-9.94

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$7M

Total Liabilities

$1M

Stockholders' Equity

$6M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$25,000	-$21,000	-19.0%
Operating Income	-$1M	-$2M	+24.8%
Net Income	-$1M	-$2M	+20.7%